Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

NCT01922128 ↗

Phase 1 Completed 20 enrolled MacuCLEAR, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to evaluate the safety and tolerability of MC-1101, a potential topical treatment for non-edxudative age Related Macular Degeneration (AMD) in medically stable individuals.

Timeline

Start: 2013-09
Primary completion: 2013-11
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Hydralazine	Small molecule	1 %	Topical

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Summary

Timeline

Drugs

Indications